ASCO® 2023 Insights: "Pirtobrutinib in cBTKi Pre-Treated MCL - Updated Results & Subgroup Analysis From the Phase 1/2 BRUIN Study With 2 Years of Survival Follow-Up"

237 views
June 14, 2023
0 Comments
Login to view comments. Click here to Login